Apogem Capital · 10 hours ago
Senior Associate, LIS Tool Developer
Apogem Capital, a part of New York Life, is seeking a Senior Associate, LIS Tool Developer to support their Core Modernization initiative. In this role, you will develop, test, and maintain Excel-based scenario testing tools for retail life insurance products, ensuring accurate policy administration as the company transitions to new technology.
Financial Services
Responsibilities
Design and update scenario testing tools in Excel to support product configuration and lifecycle analysis for our Retail Life products
Collaborate with the Automation Development team to integrate automation features and ensure effective interaction with the testing tools
Monitor tool efficiency and reliability, making adjustments as needed to improve usability and performance
Provide clear documentation and communicate findings within the team to support ongoing product development and modernization efforts
Qualification
Required
Extensive knowledge of Life Insurance products and product functionality
Strong Excel skills
General understanding of IRC Section 7702 and 7702A
Strong communication skills
Preferred
Experience working in Excel with Visual Basic for Applications (VBA)
Experience working in an Agile software development environment
Working knowledge of the QA review and testing process, designing test scenarios, including understanding various testing techniques and tools, and technology impacts
Benefits
Leave programs
Adoption assistance
Student loan repayment programs
Company
Apogem Capital
Apogem Capital is an alternatives investor, with decades of experience investing in the middle market.
H1B Sponsorship
Apogem Capital has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2022 (1)
Funding
Current Stage
Growth StageRecent News
AltAssets Private Equity News
2025-11-26
2025-11-24
Company data provided by crunchbase